VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,089,614 | +15.9% | 40,491 | +29.7% | 1.52% | +196.7% |
Q2 2023 | $940,095 | -5.9% | 31,222 | +1.1% | 0.51% | -19.8% |
Q1 2023 | $998,645 | +11.9% | 30,870 | -0.9% | 0.64% | -70.1% |
Q4 2022 | $892,360 | -75.3% | 31,136 | -76.4% | 2.13% | -11.2% |
Q2 2022 | $3,612,000 | -30.0% | 132,027 | -1.9% | 2.40% | -38.9% |
Q1 2022 | $5,160,000 | -6.3% | 134,542 | -21.7% | 3.93% | +65.4% |
Q4 2021 | $5,507,000 | +14.2% | 171,937 | +5.2% | 2.38% | +11.7% |
Q3 2021 | $4,823,000 | -13.2% | 163,450 | -0.1% | 2.13% | -2.8% |
Q2 2021 | $5,554,000 | +2.2% | 163,581 | -2.3% | 2.19% | -9.0% |
Q1 2021 | $5,434,000 | -11.8% | 167,403 | -2.1% | 2.41% | -25.5% |
Q4 2020 | $6,159,000 | -4.6% | 170,978 | +3.7% | 3.23% | -65.7% |
Q3 2020 | $6,454,000 | +5.9% | 164,820 | -0.8% | 9.42% | +137.7% |
Q2 2020 | $6,097,000 | +381.2% | 166,232 | +202.2% | 3.96% | +179.4% |
Q1 2020 | $1,267,000 | -81.6% | 55,000 | -82.1% | 1.42% | -81.8% |
Q1 2019 | $6,887,000 | – | 307,161 | – | 7.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |